MedTrace Logo

A Pragmatic Randomized Controlled Trial of Chinese Herbal Medicine for Severe Pandemic H1N1 Influenza

NCT01053533 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1100

Last updated 2010-06-08

No results posted yet for this study

Summary

The aim of this study is to evaluate the effectiveness and safety of Chinese herbal medicines for severe pandemic H1N1 influenza.

Conditions

  • Influenza A Virus, H1N1 Subtype

Interventions

DRUG

Chinese herbal medicines plus western therapy

injections of Chinese herbal medicines and Chinese herbal medicines decoction\& supportive therapy and antivirus therapy when necessary

DRUG

western therapy

supportive therapy and antivirus therapy when necessary

Sponsors & Collaborators

  • Beijing University of Chinese Medicine

    collaborator OTHER

  • State Administration of Traditional Chinese Medicine of the People's Republic of China

    collaborator OTHER_GOV

  • China Academy of Chinese Medical Sciences

    collaborator OTHER

  • Beijing Ditan Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-04-30
Completion
2010-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01053533 on ClinicalTrials.gov